Despite our previous results obtained in mouse models indicate that DRD3-signalling in CD4+ T-cells favours the development of PD (13), our results obtained from PD patients show a significant and selective reduction of DRD3 expression in CD4+ T-cells obtained from peripheral blood in comparison to those obtained from HC (Figure 1). This evidence concerns the gene DRD3 and Parkinson disease.